General & Plastic Surgery Devices - North America

The General & Plastic Surgery Devices market market in North America is expected to achieve a projected revenue of US$10.88bn in 2024.
The revenue is anticipated to display a compound annual growth rate (CAGR 2024-2029) of 5.40%, leading to a market volume of US$14.16bn by 2029.
In terms of global comparison, the United States will generate the majority of revenue, with US$9.84bn in 2024.
In North America, the demand for General & Plastic Surgery Devices is driven by the high prevalence of cosmetic procedures and advanced healthcare infrastructure.

Definition:
The General & Plastic Surgery Devices market represents medical devices designed for general and plastic surgery procedures, such as disposable surgical supplies, open surgery instruments, minimally invasive surgery instruments.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Johnson & Johnson, Becton Dickinson, Conmed Corporation. Further information on the key players can be found in the Market Shares boxes.

Disposable surgical supplies
Open surgery instruments
Minimally invasive surgery instruments

Services (i.e., treatment expenses)
Blood and transplants derived from the human body
In vitro diagnostics
Diagnostic imaging

The General & Plastic Surgery Devices market in North America is experiencing steady growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the General & Plastic Surgery Devices market in North America are driving the growth of the industry. Customers are increasingly seeking minimally invasive procedures with shorter recovery times and less scarring. This has led to an increased demand for devices such as lasers, injectable fillers, and non-surgical skin tightening devices. Additionally, customers are looking for personalized and natural-looking results, which has fueled the demand for advanced imaging and 3D simulation technologies. Trends in the market are also contributing to the growth of the General & Plastic Surgery Devices market in North America. Advancements in technology have led to the development of innovative devices that offer better outcomes and improved patient experiences. For example, the introduction of robotic-assisted surgical devices has allowed for more precise and less invasive procedures. Furthermore, the increasing popularity of non-surgical procedures, such as Botox and dermal fillers, has created a new market segment for devices that cater to these treatments. Local special circumstances in North America are also impacting the General & Plastic Surgery Devices market. The region has a large population of individuals who are conscious of their appearance and willing to invest in cosmetic procedures. Additionally, North America has a well-established healthcare infrastructure and a high level of disposable income, which allows for greater access to advanced surgical and non-surgical treatments. These factors have contributed to the growth of the market in the region. Underlying macroeconomic factors are also driving the growth of the General & Plastic Surgery Devices market in North America. The region has a stable economy and a strong healthcare system, which has created a favorable environment for the development and adoption of new technologies. Additionally, the aging population in North America has increased the demand for cosmetic procedures, as individuals seek to maintain a youthful appearance. The rise in disposable income and the availability of financing options have also made these procedures more affordable and accessible to a larger population. In conclusion, the General & Plastic Surgery Devices market in North America is experiencing growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The demand for minimally invasive procedures, advancements in technology, a population conscious of appearance, and a stable economy have all contributed to the expansion of the market in the region.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.